This Beat episode, featuring Joel Dunning, MD, focuses on survivors' longitudinal functional status of ECMO after COVID-19, a trial on advanced reperfusion strategies, an analysis on the decrease in all adult surgeries, and results of robotically-assisted congenital cardiac surgery. For more information on this episode's topics, links are provided:
- What Does Survival Look Like After ECMO for COVID-19? Small registry highlights need to analyze survivors' longitudinal functional status
- https://www.medpagetoday.com/meetingcoverage/sts/90972
- Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
- https://www.thelancet.com/article/S0140-6736(20)32338-2/fulltext
- An analysis of national data revealed a 53% decrease in all adult heart surgeries, including a 40% decline in non-elective heart surgeries and a 65% drop in elective heart surgeries during the pandemic, compared to 2019.
- https://consumer.healthday.com/b-2-2-pandemic-has-cut-heart-surgeries-in-half-and-more-patients-are-dying-2650177681.html
- https://www.ctsnet.org/article/totally-endoscopic-transaortic-septal-myectomy-hypertrophic-cardiomyopathy
- Early Results of Robotically Assisted Congenital Cardiac Surgery: Analysis of 242 Patients : JANS posting
- https://www.ctsnet.org/jans/early-results-robotically-assisted-congenital-cardiac-surgery-analysis-242-patients